Prucalopride (New drug). In chronic constipation: Poorly documented risks

Prescrire International

Volumn 20, Issue 116, 2011, Pages 117-120

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; CYTOCHROME P450; CYTOCHROME P450 3A4; GLYCOPROTEIN P; LAXATIVE; PLACEBO; PROLACTIN; PRUCALOPRIDE; TEGASEROD; BENZOFURAN DERIVATIVE; SEROTONIN 4 AGONIST;

BEHAVIOR CHANGE; BLOOD PRESSURE; CONSTIPATION; CONTRACEPTION; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; FEMALE; GERIATRIC PATIENT; HEART PALPITATION; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; LIVER TUMOR; NONHUMAN; RISK BENEFIT ANALYSIS; SHORT SURVEY; SPONTANEOUS ABORTION; THYROID TUMOR; ANIMAL; ARTICLE; CHRONIC DISEASE; DRUG APPROVAL; EUROPEAN UNION; MALE; PREGNANCY;

ANIMALS; BENZOFURANS; CHRONIC DISEASE; CONSTIPATION; DRUG APPROVAL; EUROPEAN UNION; FEMALE; HUMANS; MALE; PREGNANCY; SEROTONIN 5-HT4 RECEPTOR AGONISTS;

EID: 79955700282     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Prescrire Rédaction "Constipation de l'adulte. Prise en charge dans le cadre des soins primaires" Rev Prescrire 2004; 24 (254): 688-698.
2. "Constipation". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 2 November 2010: 4 pages.
3. de Maeyer JH et al. "5-HT4 receptor agonists: similar but not the same" Neurogastroenterol Motil 2008; 20: 99-112.
4. European Medicines Agency - CHMP "Assessment report for Resolor. EMEA/H/C/1012" posted on the EMA website 18 August 2009: 49 pages.
5. 5- Camilleri M et al. "A placebo-controlled trial of prucalopride for severe chronic constipation" N Engl J Med 2008; 358 (22): 2344-2354. (Pubitemid 351749158)
6. Quigley EM et al. "Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: a 12-week, randomized, double-blind, placebo-controlled study" Aliment Pharmacol Ther 2009; 29 (3): 315-318.
7. Tack J et al. "Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives" Gut 2009; 58 (3): 357-365.
8. Müller-Lissner S et al. "A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation" Neurogastroenterol Motil 2010; 22: 991-999.
9. European Commission "Summary of Product Characteristics - Resolor" 15 October 2009: 9 pages.
10. Prescrire Rédaction "Comment évaluer le niveau de risque d'un traitement pour un patient donné?" Rev Prescrire 2009; 29 (305): 235-236.
11. Prescrire Rédaction "Fiche 12. La glycoprotéine P en bref" Rev Prescrire 2010; 30 (326 suppl. interactions mé dicamenteuses).
12. 12- Moss AJ "The long and short of a constipation-reducing medication" N Engl J Med 2008; 22: 2402-2403. (Pubitemid 351749168)
13. Prescrire Editorial Staff "Severe cardiac arrhythmia on cisapride" Prescrire Int 2000; 9 (49): 144-145.